Udo Oppermann

21.0k total citations · 2 hit papers
241 papers, 13.8k citations indexed

About

Udo Oppermann is a scholar working on Molecular Biology, Endocrinology, Diabetes and Metabolism and Cell Biology. According to data from OpenAlex, Udo Oppermann has authored 241 papers receiving a total of 13.8k indexed citations (citations by other indexed papers that have themselves been cited), including 171 papers in Molecular Biology, 43 papers in Endocrinology, Diabetes and Metabolism and 42 papers in Cell Biology. Recurrent topics in Udo Oppermann's work include Epigenetics and DNA Methylation (42 papers), Hormonal Regulation and Hypertension (34 papers) and Aldose Reductase and Taurine (32 papers). Udo Oppermann is often cited by papers focused on Epigenetics and DNA Methylation (42 papers), Hormonal Regulation and Hypertension (34 papers) and Aldose Reductase and Taurine (32 papers). Udo Oppermann collaborates with scholars based in United Kingdom, Sweden and United States. Udo Oppermann's co-authors include K.L. Kavanagh, Bengt Persson, Hans Jörnvall, Yvonne Kallberg, Hans Jörnvall, Charlotta Filling, Xiaoqiu Wu, Christopher J. Schofield, James E. Dunford and Edmund Maser and has published in prestigious journals such as Nature, Proceedings of the National Academy of Sciences and Journal of the American Chemical Society.

In The Last Decade

Udo Oppermann

239 papers receiving 13.6k citations

Hit Papers

align trajectories sort by overperformance

What are hit papers?

Hit papers significantly outperform the citation benchmark for their cohort. A paper qualifies if it has ≥500 total citations, achieves ≥1.5× the top-1% citation threshold for papers in the same subfield and year (this is the minimum needed to enter the top 1%, not the average within it), or reaches the top citation threshold in at least one of its specific research topics.

Medium- and short-chain dehydrogenase/reductase gene and protein families

2008 699 citations K.L. Kavanagh, Udo Oppermann et al. profile →
Short-chain dehydrogenases/reductases (SDR): the 2002 update

2003 552 citations Udo Oppermann, N. Shafqat et al. profile →

Author Peers

Peers are selected by citation overlap in the author's most active subfields. citations · hero ref

Author						Papers	Cites
Udo Oppermann	8.8k	1.7k	1.6k	1.3k	1.2k	241	13.8k
Kazuhiko Igarashi	18.3k 2.1×	1.5k 0.9×	1.1k 0.7×	1.6k 1.3×	320 0.3×	269	24.5k
Lee Jia	5.2k 0.6×	3.4k 2.0×	312 0.2×	963 0.8×	1.0k 0.9×	311	13.2k
William S. Sly	13.4k 1.5×	1.3k 0.8×	873 0.5×	2.9k 2.3×	356 0.3×	328	23.7k
Gerald Litwack	9.1k 1.0×	1.5k 0.9×	1.5k 0.9×	1.1k 0.9×	295 0.2×	242	12.8k
Nancy A. Thornberry	18.3k 2.1×	4.5k 2.6×	2.1k 1.3×	2.2k 1.8×	310 0.3×	110	26.3k
Robert L. Heinrikson	7.1k 0.8×	831 0.5×	489 0.3×	1.4k 1.1×	769 0.6×	171	11.9k
Stanley T. Crooke	17.8k 2.0×	4.0k 2.3×	845 0.5×	1.1k 0.8×	603 0.5×	415	25.7k
Carlo Riccardi	6.3k 0.7×	3.1k 1.8×	1.0k 0.6×	535 0.4×	216 0.2×	316	17.8k
Eugene P. Kennedy	9.0k 1.0×	2.5k 1.5×	750 0.5×	1.8k 1.4×	583 0.5×	236	16.9k
Yi Sun	11.2k 1.3×	4.3k 2.5×	609 0.4×	1.7k 1.3×	199 0.2×	287	18.5k

Countries citing papers authored by Udo Oppermann

Since Specialization

Citations

This map shows the geographic impact of Udo Oppermann's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Udo Oppermann with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Udo Oppermann more than expected).

Fields of papers citing papers by Udo Oppermann

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Udo Oppermann. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Udo Oppermann. The network helps show where Udo Oppermann may publish in the future.

Co-authorship network of co-authors of Udo Oppermann

This figure shows the co-authorship network connecting the top 25 collaborators of Udo Oppermann. A scholar is included among the top collaborators of Udo Oppermann based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Udo Oppermann. Udo Oppermann is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

20 of 20 papers shown

Sun, Jianfeng, Martin Philpott, Gary Hoffmann, et al.. (2025). Enhancing single-cell transcriptomics using interposed anchor oligonucleotide sequences. Communications Biology. 8(1). 67–67. 2 indexed citations

Oekelen, Oliver Van, Michael Amatangelo, Manman Guo, et al.. (2024). Iberdomide increases innate and adaptive immune cell subsets in the bone marrow of patients with relapsed/refractory multiple myeloma. Cell Reports Medicine. 5(6). 101584–101584. 7 indexed citations

Brown, Elizabeth, Adam P. Cribbs, Martin Philpott, et al.. (2024). PRMT5 inhibition shows in vitro efficacy against H3K27M-altered diffuse midline glioma, but does not extend survival in vivo. Scientific Reports. 14(1). 328–328. 4 indexed citations

Yutuc, Eylan, Catherine A. Thornton, James E. Dunford, et al.. (2023). HSD3B1 is an oxysterol 3β-hydroxysteroid dehydrogenase in human placenta. Open Biology. 13(5). 220313–220313. 4 indexed citations

Agarwal, Gaurav, Lisa Ferguson, Jaimal Kothari, et al.. (2023). Targeted NGS Panel Guides Risk-Adapted Treatment Intention in Newly Diagnosed Myeloma Patients. Blood. 142(Supplement 1). 644–644. 1 indexed citations

Davis‐Gilbert, Zachary W., Andreas Krämer, James E. Dunford, et al.. (2023). Discovery of a Potent and Selective Naphthyridine-Based Chemical Probe for Casein Kinase 2. ACS Medicinal Chemistry Letters. 14(4). 432–441. 11 indexed citations

Ramasamy, Karthik, Ross Sadler, Alison Turner, et al.. (2022). Immune response to COVID ‐19 vaccination is attenuated by poor disease control and antimyeloma therapy with vaccine driven divergent T‐cell response. British Journal of Haematology. 197(3). 293–301. 14 indexed citations

Payne, N. Connor, C. Johansson, Sofia A. Santos, et al.. (2022). Elucidating the path to Plasmodium prolyl-tRNA synthetase inhibitors that overcome halofuginone resistance. Nature Communications. 13(1). 4976–4976. 16 indexed citations

Cribbs, Adam P., Martin Philpott, Jeroen Baardman, et al.. (2020). Histone H3K27me3 demethylases regulate human Th17 cell development and effector functions by impacting on metabolism. Proceedings of the National Academy of Sciences. 117(11). 6056–6066. 73 indexed citations

10.

Cottone, Lucia, Adam P. Cribbs, Garima Khandelwal, et al.. (2020). Inhibition of Histone H3K27 Demethylases Inactivates Brachyury (TBXT) and Promotes Chordoma Cell Death. Cancer Research. 80(20). 4540–4551. 35 indexed citations

11.

Muniz, J.R.C., Rebecca Frise, Wen‐Hwa Lee, et al.. (2019). Role of protein structure in variant annotation: structural insight of mutations causing 6-pyruvoyl-tetrahydropterin synthase deficiency. Pathology. 51(3). 274–280. 7 indexed citations

12.

Amatangelo, Michael, Oliver Van Oekelen, Adeeb Rahman, et al.. (2019). Multidimensional Single Cell Analysis Shows Increased T/NK Cell Subsets in Both Blood and Bone Marrow of Iberdomide (CC-220) Treated Relapsed/Refractory Multiple Myeloma Patients. Blood. 134(Supplement_1). 1775–1775. 9 indexed citations

13.

Sur‐Erdem, İlknur, Fidan Seker-Polat, Ahmet Cingöz, et al.. (2019). The fungal metabolite chaetocin is a sensitizer for pro-apoptotic therapies in glioblastoma. Cell Death and Disease. 10(12). 894–894. 26 indexed citations

14.

Yang, Shyh‐Ming, Natalia J. Martinez, Adam Yasgar, et al.. (2018). Discovery of Orally Bioavailable, Quinoline-Based Aldehyde Dehydrogenase 1A1 (ALDH1A1) Inhibitors with Potent Cellular Activity. Journal of Medicinal Chemistry. 61(11). 4883–4903. 70 indexed citations

15.

Bergqvist, Filip, Alan Carr, Kim Wheway, et al.. (2018). Prostacyclin: a potential novel therapeutic target to treat tendon pain and inflammation. Scandinavian Journal of Rheumatology. 47. 17–18. 1 indexed citations

16.

Kumar, Kiran, Bas J. G. E. Pieters, Anthony Tumber, et al.. (2017). Investigatingd-lysine stereochemistry for epigenetic methylation, demethylation and recognition. Chemical Communications. 53(99). 13264–13267. 26 indexed citations

17.

Sakurai, Masaaki, Nathan R. Rose, Lena Schultz, et al.. (2009). A miniaturized screen for inhibitors of Jumonji histonedemethylases. Molecular BioSystems. 6(2). 357–364. 76 indexed citations

18.

Sveshnikov, Dmitry, et al.. (2009). Tic32, an essential component in chloroplast biogenesis. (vol 279, pg 34756, 2004). Journal of Biological Chemistry. 284. 29240–29240. 5 indexed citations

19.

Simeonov, Anton, Adam Yasgar, Wei Zheng, et al.. (2007). Evaluation of Micro-Parallel Liquid Chromatography as a Method for HTS-Coupled Actives Verification. Assay and Drug Development Technologies. 5(6). 815–824. 4 indexed citations

20.

Dunford, James E., et al.. (2007). Kinetic analysis of conformational changes in farnesyl pyrophosphate synthase induced by nitrogen containing bisphosphonates. Calcified Tissue International. 40. 3 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact